Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Megastudies improve the impact of applied behavioural science
Milkman, Katherine L.; Gromet, Dena; Ho, Hung; Kay, Joseph S.; Lee, Timothy W.; Pandiloski, Pepi; Park, Yeji; Rai, Aneesh; Bazerman, Max; Beshears, John; Bonacorsi, Lauri; Camerer, Colin; Chang, Edward; Chapman, Gretchen; Cialdini, Robert; Dai, Hengchen; Eskreis-Winkler, Lauren; Fishbach, Ayelet; Gross, James J.; Horn, Samantha; Hubbard, Alexa; Jones, Steven J.; Karlan, Dean; Kautz, Tim; Kirgios, Erika; Klusowski, Joowon; Kristal, Ariella; Ladhania, Rahul; Loewenstein, George; Ludwig, Jens; Mellers, Barbara; Mullainathan, Sendhil; Saccardo, Silvia; Spiess, Jann; Suri, Gaurav; Talloen, Joachim H.; Taxer, Jamie; Trope, Yaacov; Ungar, Lyle; Volpp, Kevin G.; Whillans, Ashley; Zinman, Jonathan; Duckworth, Angela L. Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save BUDGET IMPACT OF RIBOCICLIB PLUS LETROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR plus ), HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2-) ADVANCED OR METASTATIC BREAST CANCER FROM A US PRIVATE THIRD-PARTY PAYER PERSPECTIVEMistry, R.; Suri, G.; Young, K. C.; Hettle, R.; May, J. R.; Brixner, D.; Oderda, G.; Biskupiak, J.; Tang, D.; Bhattacharyya, D.; Bhattacharyya, S.; Mishra, D.; Dalal, A. Share Save Share Save COST EFFECTIVENESS OF RIBOCICLIB PLUS LETROZOLE VERSUS PALBOCICLIB PLUS LETROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR plus ), HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2-) ADVANCED OR METASTATIC BREAST CANCER FROM A US PRIVATE THIRD-PARTY PAYER PERSPECTIVESuri, G.; Mistry, R.; Young, K. C.; Hettle, R.; May, J. R.; Brixner, D.; Oderda, G.; Biskupiak, J.; Tang, D.; Bhattacharyya, D.; Bhattacharyya, S.; Mishra, D.; Dalal, A. Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
